Revised forecast
Fiscal year ending September 2026 · Full yearPrevious forecast published Announced on 14 November 2025 (initial forecast; the previous forecast announced on 14 August 2026 was undetermined)The bar length represents the relative magnitude of change, based on the item that changed the most in this document.
The company prioritized expanding GMV and accepted a decline in its gross margin on GMV, while the start of measures to revise fees received from counterparties was delayed and negotiations on terms with business partners took longer than expected. SG&A expenses increased due to investments in infrastructure and security enhancements, AI and human resources, as well as impairment losses.
Impairment loss of ¥65 million. Impairment is expected to be required for part of the ¥129 million in assets subject to impairment testing, but the specific amount has not been finalized and may change.
| Item | Details |
|---|---|
| Net Sales | ¥1,700 million → ¥1,699 million（-0.1%） |
| Operating profit | ¥200 million → ¥14 million（-93.0%） |
| Fiscal Period Covered | Fiscal year ending September 2026 |
| Period Covered | Full year |
| Publication date of previous forecast | Announced on 14 November 2025 (initial forecast; the previous forecast announced on 14 August 2026 was undetermined) |
| Previous-period results | Revenue of ¥933 million, operating profit before rewards of ¥54 million, operating profit before impairment losses of ¥24 million, operating loss of ¥3 million, loss before income taxes of ¥36 million, net loss attributable to owners of the parent of ¥71 million, and basic loss per share of ¥16.73 |
| Reason for the revision | The company prioritized expanding GMV and accepted a decline in its gross margin on GMV, while the start of measures to revise fees received from counterparties was delayed and negotiations on terms with business partners took longer than expected. SG&A expenses increased due to investments in infrastructure and security enhancements, AI and human resources, as well as impairment losses. |
| Details and amount of extraordinary loss | Impairment loss of ¥65 million. Impairment is expected to be required for part of the ¥129 million in assets subject to impairment testing, but the specific amount has not been finalized and may change. |
| Consolidated / non-consolidated | Consolidated |
Items this document does not state (4)
These are items the company does not state in this document. We do not leave them blank, nor fill them in from other sources or by inference.
The reasons the company gives
The company's own explanation, not something inferred from the numbers.The company prioritized expanding GMV and accepted a decline in its gross margin on GMV, while the start of measures to revise fees received from counterparties was delayed and negotiations on terms with business partners took longer than expected. SG&A expenses also increased due to investment in infrastructure and security enhancements, AI and human resources, as well as impairment losses.